Goldman Sachs heads into its July 14 Q2 earnings report having reclaimed $1,043 — up 3.1% on the week — with analysts rushing to lift targets and options traders the most call-skewed they have been in a year.
The most striking development this week is not price action but analyst re-rating velocity. B of A Securities raised its target to $1,150 from $1,050 on July 7, maintaining Buy. UBS lifted to $1,120 from $940 the same morning, keeping Neutral. Evercore ISI moved to $1,075 from $950 on July 6 with an Outperform. Those three moves — all within 48 hours — mark a clear acceleration in upward target revisions after weeks of more cautious positioning. Taken together, the Street has shifted from split skepticism to broadly bullish in tone, even if ratings themselves remain mixed. The consensus mean target is $1,009.70, now below the current price at $1,043, which suggests the cluster of recent upgrades has not yet fully flowed through the aggregate. Wells Fargo's Mike Mayo holds the highest published target at $1,195 with Overweight. Oppenheimer's Underperform, issued June 30, stands as the lone bear call and looks increasingly isolated.
The lending market tells a consistent story: shorts are not making a statement here. Short interest is running at 2.17% of free float — essentially flat to last week's 2.23% and not far from multi-month lows. Borrow costs are minimal at 0.42%, up modestly on the week but still well within the range of a routinely easy borrow. Availability is extraordinarily loose at over 7,800% of short interest, meaning there are roughly 78 shares available to lend for every one already borrowed. That is not the profile of a stock under meaningful short pressure. Options positioning reinforces the constructive lean: the put/call ratio is at 0.83, running more than one standard deviation below its 20-day average of 0.90 and close to the 52-week low of 0.80. Call demand has been outpacing puts consistently since mid-June, when the PCR was running near 0.97.
The bull case rests on M&A advisory momentum, expanding asset and wealth management revenues, and the ongoing diversification away from capital-markets volatility. Bears — principally Oppenheimer — flag FICC trading risk, regulatory headwinds, and macro sensitivity. On valuation, the stock trades at a price/earnings multiple of roughly 17.3x and 2.8x book. Both have expanded over the past month as the price recovered from its early-July lows near $1,011. The EPS surprise factor score at the 72nd percentile, and a dividend score at the 86th percentile, reinforce the quality-of-earnings angle the bulls have been emphasizing. The ORTEX short score of 33.2 sits well below the midpoint, consistent with minimal squeeze risk and a broadly benign short-side setup.
Peers moved broadly in step this week. MS gained 4.9% on the week, JEF added 8.3%, and MC led the group with 11%. GS's 3.1% compares favorably with its own recent weeks but trails the broader peer rally — a reminder that even with target upgrades, the stock is recapturing ground rather than breaking new territory. Earnings history is thin on dramatic reactions: the April 13 Q1 print produced a negligible next-day move of +0.2%, though the five-day drift reached +3.7%.
What matters from here is whether Q2 results on July 14 can validate the target-raising that analysts have front-run over the past two weeks — and whether trading revenues and advisory fees landed where the bullish framing implies.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
